Fusion Pharmaceuticals Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() BCAB
BioAtla, Inc. |
$0.38 | $73.14 M | -0.61 | 65 | $0 |
![]() BCYC
Bicycle Therapeutics plc |
$11.84 | $982.26 M | -5.24 | 284 | $26.98 M |
![]() BOLT
Bolt Biotherapeutics, Inc. |
$0.47 | $29.02 M | -0.46 | 100 | $7.88 M |
![]() CHRS
Coherus BioSciences, Inc. |
$1.17 | $193.89 M | -2.28 | 235 | $257.24 M |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.34 | $1.65 B | -11.47 | 108 | $0 |
![]() FENC
Fennec Pharmaceuticals Inc. |
$6.67 | $187.43 M | 171.5 | 29 | $21.25 M |
![]() GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
![]() HRMY
Harmony Biosciences Holdings, Inc. |
$37.99 | $1.73 B | 13.15 | 246 | $582.02 M |
![]() IKNA
Ikena Oncology, Inc. |
$1.43 | $84.45 M | -1.11 | 14 | $9.16 M |
![]() JANX
Janux Therapeutics, Inc. |
$37.80 | $2.29 B | -36.8 | 76 | $8.08 M |
![]() KROS
Keros Therapeutics, Inc. |
$10.49 | $1.76 B | -9.45 | 160 | $151,000 |
![]() NAMS
NewAmsterdam Pharma Company N.V. |
$19.26 | $1.74 B | -7.15 | 62 | $12.76 M |
![]() NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
![]() OLMA
Olema Pharmaceuticals, Inc. |
$5.16 | $734.41 M | -6.56 | 74 | $0 |
![]() PASG
Passage Bio, Inc. |
$0.57 | $73.04 M | -0.77 | 58 | $0 |
![]() PMVP
PMV Pharmaceuticals, Inc. |
$1.43 | $85.40 M | -1.26 | 63 | $0 |
![]() RAPT
RAPT Therapeutics, Inc. |
$1.15 | $134.03 M | -1.25 | 70 | $0 |
![]() RLMD
Relmada Therapeutics, Inc. |
$0.31 | $89.01 M | -0.94 | 20 | $0 |
![]() SPRO
Spero Therapeutics, Inc. |
$0.80 | $75.85 M | 3.19 | 46 | $96.74 M |